Trial Profile
Effect of ONO-8539 on Transient Lower Esophageal Sphincterreluxation in healthy male volunteer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2021
Price :
$35
*
At a glance
- Drugs ONO 8539 (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 05 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 09 May 2017 Results (n=10), presented at the Digestive Disease Week 2017
- 17 Dec 2015 Planned End Date changed from 30 Jun 2015 to 31 Dec 2016 as reported by University Hospital Medical Information Network record.